| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Göteborg University, S-413 45 Gothenburg, Sweden
The Epstein—Barr virus (EBV) nuclear antigen 2 (EBNA2) is one of the first EBV-encoded gene products expressed after infection of primary B lymphocytes. EBNA2 is essential for the growth-transforming potential of the virus and it functions as a transcriptional activator of a set of viral and cellular genes. Sequence-specific DNA-binding by EBNA2 has not been demonstrated but the molecule is targeted to specific DNA regions by a cellular protein, RBP-J
, which recognizes the GTGGGAA sequence present in the regulatory region of all EBNA2-responsive promoters defined so far. We have determined the contribution of a RBP-J recognition sequence, an adjacent interferon-stimulated response element (ISRE) motif and a PU.1-binding site in the LMP1 regulatory sequence (LRS) to EBNA2-induced transactivation of the promoter by site-directed mutagenesis of LRS-carrying reporter plasmids. EBNA2 responsiveness was reduced by approximately twofold when either or both of the RBP-J-binding and ISRE sequences were mutated. ISRE seemed to function as an EBNA2-independent positive element. On the other hand, mutation of the PU box resulted in a drastic reduction of EBNA2 responsiveness, irrespective of whether the RBP-J site or the ISRE motif was present. A comparative study by deletion mutation identified regions of EBV B95-8 EBNA2 involved in the transactivation of the LMP1 and the EBNA Cp promoters. Two domains of EBNA2 defined by deletion of amino acids 247–337 and 437–476 were found to be important for the activation of both promoters, while two different domains corresponding to residues 4–18 and 118–198 were required solely for the LMP1 promoter. Thus, EBNA2 must activate the LMP1 and Cp promoters by different mechanisms. All deletions involved in transcriptional activation of the two promoters contained regions that are conserved in EBNA2 of B95-8 EBV (type 1), AG876 EBV (type 2) and herpesvirus papio origin.
* Author for correspondence. Fax +46 31 828458. e-mail lars.rymo@ss.gu.se
Received 29 March 1995;
accepted 9 June 1995.
This article has been cited by other articles:
|
|
 |
|
  P. M. Pegman, S. M. Smith, B. N. D'Souza, S. T. Loughran, S. Maier, B. Kempkes, P. A. Cahill, M. J. Simmons, C. Gelinas, and D. Walls Epstein-Barr Virus Nuclear Antigen 2 trans-Activates the Cellular Antiapoptotic bfl-1 Gene by a CBF1/RBPJ{kappa}-Dependent Pathway. J. Virol., August 1, 2006; 80(16): 8133 - 8144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ning, L. E. Huye, and J. S. Pagano Interferon Regulatory Factor 5 Represses Expression of the Epstein-Barr Virus Oncoprotein LMP1: Braking of the IRF7/LMP1 Regulatory Circuit J. Virol., September 15, 2005; 79(18): 11671 - 11676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-W. Peng, B. Zhao, and E. Kieff Four EBNA2 Domains Are Important for EBNALP Coactivation J. Virol., October 15, 2004; 78(20): 11439 - 11442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gordadze, C. W. Onunwor, R. Peng, D. Poston, E. Kremmer, and P. D. Ling EBNA2 Amino Acids 3 to 30 Are Required for Induction of LMP-1 and Immortalization Maintenance J. Virol., April 15, 2004; 78(8): 3919 - 3929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yue, M. G. Davenport, J. Shackelford, and J. S. Pagano Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function J. Virol., April 1, 2004; 78(7): 3542 - 3552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ning, A. M. Hahn, L. E. Huye, and J. S. Pagano Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit J. Virol., September 1, 2003; 77(17): 9359 - 9368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Groves, M. A. Cotter, C. Subramanian, and E. S. Robertson The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters J. Virol., October 1, 2001; 75(19): 9446 - 9457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H. H. Niller Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus J. Virol., March 15, 2001; 75(6): 2584 - 2596. [Abstract] [Full Text]
|
|
|
|
|
|
A. Sjöblom-Hallén, W. Yang, A. Jansson, and L. Rymo Silencing of the Epstein-Barr Virus Latent Membrane Protein 1 Gene by the Max-Mad1-mSin3A Modulator of Chromatin Structure J. Virol., April 1, 1999; 73(4): 2983 - 2993. [Abstract] [Full Text]
|
|
|
|
|
|
S. Harada, R. Yalamanchili, and E. Kieff Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation J. Virol., December 1, 1998; 72(12): 9948 - 9954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. I. Falk, L. Szekely, A. Aleman, and I. Ernberg Specific Methylation Patterns in Two Control Regions of Epstein-Barr Virus Latency: the LMP-1-Coding Upstream Regulatory Region and an Origin of DNA Replication (oriP) J. Virol., April 1, 1998; 72(4): 2969 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sjoblom, W. Yang, L. Palmqvist, A. Jansson, and L. Rymo An ATF/CRE Element Mediates both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter J. Virol., February 1, 1998; 72(2): 1365 - 1376. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
